Back to trial details

Intake questionnaire

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Applying to Dana-Farber Cancer Institute · Boston, Massachusetts

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumors With KRAS G12C Mutations?
3. Are you able to travel to Boston for study visits?